Bicarbonate

Bicarbonate

SCHEMBL2962235

O=C([O-])O.[Hg+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL35983 0.88
Bicarbonate SCHEMBL30997 0.88
Bicarbonate SCHEMBL6130594 0.88 CA4 (0.46)
Bicarbonate SCHEMBL6130595 0.88 CA4 (0.46)
Bicarbonate SCHEMBL4380354 0.88 CA4 (0.46)
Bicarbonate SCHEMBL25206526 0.88 CA4 (0.46)
Bicarbonate SCHEMBL15321596 0.88 CA4 (0.60)
Bicarbonate SCHEMBL21815629 0.88 CA4 (0.46)
Bicarbonate SCHEMBL21526742 0.88
Bicarbonate SCHEMBL1332636 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102115155-A Method for preparing mercury bicarbonate and calcium chloride by using mercury-containing waste catalyst XIA HE 2011-07-06 CN claimed
US-20260027072-A1 COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS INC (US) 2026-01-29 US disclosed
CN-110520111-B Pharmaceutical formulation and method for managing body weight and regulating intestinal microbiota 塞诺生物科学股份有限公司 2023-12-19 CN disclosed
US-20220331355-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA LPOXY THERAPEUTICS, INC. 2022-10-20 US disclosed
CN-107921073-B Methods and compositions for regulating gut microbiota and managing weight 塞诺生物科学股份有限公司 2022-10-18 CN disclosed
US-11311573-B2 Pharmaceutical preparations and methods to manage weight and to modulate the gut microbiota XENO BIOSCIENCES INC. (US) 2022-04-26 US disclosed
CN-110520111-A To manage weight and adjust the pharmaceutical preparation and method of intestinal microbiota XENO BIOSCIENCES INC 2019-11-29 CN disclosed
CN-107921073-A For adjusting intestinal microbiota and managing the method and composition of weight 塞诺生物科学股份有限公司 2018-04-17 CN disclosed
EP-1707257-B1 Method for manufacturing particles and toner particles RICOH CO LTD (JP) 2016-06-01 EP disclosed
CN-102115155-A Method for preparing mercury bicarbonate and calcium chloride by using mercury-containing waste catalyst XIA HE 2011-07-06 CN disclosed
CN-102115155-A Method for preparing mercury bicarbonate and calcium chloride by using mercury-containing waste catalyst XIA HE 2011-07-06 CN disclosed
CN-102115155-A Method for preparing mercury bicarbonate and calcium chloride by using mercury-containing waste catalyst XIA HE 2011-07-06 CN disclosed
US-7776503-B2 Particles and manufacturing method thereof, toner and manufacturing method thereof, and developer, toner container, process cartridge, image forming method and image forming apparatus RICOH COMPANY, LTD. (JP) 2010-08-17 US disclosed
US-20060222980-A1 high-pressure gas is sprayed over a viscous material while it is being discharged in a chamber for atomization, and cooling air is introduced in the chamber for granulation; high heat transfer efficiency and high productivity; for high quality image formation of electrophotography RICOH COMPANY, LTD. (JP) 2006-10-05 US disclosed
EP-1707257-A2 Particles and manufacturing method thereof, toner and manufacturing method thereof, and developer, toner container, process cartridge, image forming method and image forming apparatus Ricoh Company, Ltd. (JP) 2006-10-04 EP disclosed